Gelatinous Capsules of β-Lapachone for Anti-cancer Therapies

被引:0
|
作者
Presmich, Geisiane M. A. [1 ]
Rolim, Larissa A. [1 ]
Medeiros, Flavia P. M. [1 ,3 ]
Albuquerque, Miracy M. [2 ]
Rolim-Neto, Pedro J. [1 ]
机构
[1] Univ Fed Pernambuco, Lab Tecnol Medicamentos, Dept Ciencias Farmaceut, BR-50740521 Recife, PE, Brazil
[2] Univ Fed Pernambuco, NCQMC, BR-50740521 Recife, PE, Brazil
[3] Lab Farmaceut Estado Pernantbuco LAFEPE Largo de, BR-52171010 Recife, PE, Brazil
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2010年 / 29卷 / 05期
关键词
beta-lapachone; soft gelatinous capsules and hard; stability; PROSTATE-CANCER CELLS; MEDIATED APOPTOSIS; DERIVATIVES; INHIBITION;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
"Gelatinous Capsules of beta-Lapachone for Anti-cancer Therapies". beta-lapachone is a natural ortonaftoquinona of ipe purple growing mainly in Brazil, also obtained by the process of semi-synthesis of its isomer lapachol. It is a simple plant product that has demonstrated excellent potential in antineoplastic studies in albino rats, mice and cell cultures. Works by a particular mechanism of apoptosis against various types of cancer, especially some strains of prostate refractory to conventional treatments. It has low solubility in water, the development of a pharmaceutical form the basis of beta-lapachone providing favorable bioavailability is a key point for the continuity of research with this asset. Hard gelatine capsules containing 250 mg of beta-lapachone and soft gelatine capsules containing 30 mg beta-lapachone were developed. Due to the crystalline form and character of lipophilic beta-lapachone, the hard gelatin capsules did not show acceptable levels of dissolution, however, the soft gelatinous capsules showed satisfactory results for continuation of studies in this active.
引用
收藏
页码:674 / 680
页数:7
相关论文
共 50 条
  • [31] Translational and Comparative Research on Innovative Anti-Cancer Therapies
    Queiroga, Felisbina
    Cogliati, Bruno
    CANCERS, 2023, 15 (04)
  • [32] How to develop better screens for anti-cancer therapies?
    Hong, Michelle
    Abastado, Jean-Pierre
    ONCOIMMUNOLOGY, 2012, 1 (03): : 382 - 383
  • [33] The role of the mitochondria in mediating cytotoxicity of anti-cancer therapies
    Dao M. Nguyen
    Mustafa Hussain
    Journal of Bioenergetics and Biomembranes, 2007, 39 : 13 - 21
  • [34] Potential of Mesenchymal Stem Cells in Anti-Cancer Therapies
    Kostadinova, Milena
    Mourdjeva, Milena
    CURRENT STEM CELL RESEARCH & THERAPY, 2020, 15 (06) : 482 - 491
  • [35] ENDOCRINE SIDE EFFECTS OF ANTI-CANCER DRUGS Effects of anti-cancer targeted therapies on lipid and glucose metabolism
    Verges, Bruno
    Walter, Thomas
    Cariou, Bertrand
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 170 (02) : R43 - R55
  • [36] Cancer Metabolism, HIF-1, and Novel Anti-Cancer Therapies
    Semenza, Gregg L.
    FASEB JOURNAL, 2012, 26
  • [37] The influence of anti-cancer therapies on lymphocyte subpopulations of lung cancer patients
    Gessner, Philipp
    Tessema, Belay
    Scholz, Markus
    Sack, Ulrich
    Boldt, Andreas
    Kuehnapfel, Andreas
    Gessner, Christian
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [38] Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies
    Thakur, Chitra
    Qiu, Yiran
    Fu, Yao
    Bi, Zhuoyue
    Zhang, Wenxuan
    Ji, Haoyan
    Chen, Fei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [39] Editorial: The effect of anti-cancer drug therapies in the treatment of lung cancer
    Pisapia, Pasquale
    Li, Zhi
    Corbet, Cyril
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [40] Anti-Cancer Stem-Cell-Targeted Therapies in Prostate Cancer
    Gogola, Samantha
    Rejzer, Michael
    Bahmad, Hisham F. F.
    Alloush, Ferial
    Omarzai, Yumna
    Poppiti, Robert
    CANCERS, 2023, 15 (05)